Mandate

Vinge advises Bridgepoint in conjunction with an investment in FCG

January 25, 2018

Vinge has advised Bridgepoint Development Capital in conjunction with the entry into of a partnership in FCG Holding Sverige AB.

FCG Holding Sverige AB is one of the Nordic region’s leading suppliers of specialist services within risk management, compliance, finance and capital management, financial law and corporate governance, with a focus on the financial sector.

The transaction is conditional upon approval by the Swedish Financial Supervisory Authority.

Vinge’s team primarily consisted of partner Daniel Rosvall together with associates Samra Baytar, Michaela Cronemyr, Christina Odengran and Caroline Krassén. Malin Haag and Carolina Sandell provided advice in connection with the notification to, and approval from, the Swedish Financial Supervisory Authority.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025